Topic: Patients with limited metastases benefit from metastasis-directed therapy - Belgium took the lead in this new and promising approach.
It is with great pleasure that we announce the 2022 BRAVO Symposium to be held in Brussels on Friday March 18th.
BRAVO and BeMedTech will bring together the Belgian Radiation Oncology community in a live and in-person format that builds on the success of our 2018 symposium. This year, we continue our mission to increase awareness of radiation oncology as a safe and modern treatment method of cancer.
More information and registration.
« Go back